Africa intensifies battle against mpox as ‘alarming’ outbreaks continue
Researchers and public health officials in Africa are intensifying their battle against mpox, a neglected infectious disease that long has circulated on the continent and suddenly gained notoriety in 2022 when it started to spread rapidly in Europe and North America. At a meeting last week in Kinshasa, the capital of the DRC, scientists from there and nine other affected African countries reviewed an alarming rise of cases on the continent, discussed plans to improve mpox surveillance and introduce vaccination, and launched an African-led research consortium.
The meeting, convened by the Africa Centres for Disease Co...
Source: ScienceNOW - April 19, 2024 Category: Science Source Type: news
Evergreen Theragnostics raises $26M
Evergreen Theragnostics has raised $26 million in capital through its existing shareholders and new backers Petrichor and LIFTT.
With the funding, the Springfield, NJ-based company plans to advance commercialization of its Ga-68 DOTATOC diagnostic kit, and further its theranostic pair, EVG-321, into clinical trials. Evergreen also intends to expand its capabilities as a contract development and manufacturing organization (CDMO).
Stefano Buono, chairman of LIFTT and founder and former CEO of Advanced Accelerator Applications, noted the funding is based on optimism around rapidly advancing radioligand therapies.
Evergreen...
Source: AuntMinnie.com Headlines - April 19, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Nuclear Radiology Radiation Oncology Source Type: news
Drug Development Considerations for Empiric Antibacterial Therapy in Febrile Neutropenic Patients - 04/23/2024
The purpose of the public workshop is to discuss clinical trial design and other considerations related to the development of antibacterial drug products for treatment of febrile neutropenia (FN). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 19, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Talking to Your Doctor About CLL Clinical Trials
Are you looking for a clinical trial to help treat your chronic lymphocytic leukemia (CLL)? Find out what you need to know before you sign up. (Source: WebMD Health)
Source: WebMD Health - April 19, 2024 Category: Consumer Health News Source Type: news
One Neurological Factor Keeps Black, Hispanic Patients From Alzheimer's Clinical Trials
FRIDAY, April 19, 2024 -- Black and Hispanic patients with Alzheimer ’s disease are greatly underrepresented in clinical trials, even though they’re more likely to get dementia than whites.However, racial discrimination may not be driving this... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 19, 2024 Category: General Medicine Source Type: news
Children used as 'guinea pigs' in clinical trials
They were given infected blood products in trials without their knowledge, the BBC has found. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 18, 2024 Category: Consumer Health News Source Type: news
ProPharma Now Certified as Medidata Rave EDC Accredited Partner
ProPharma, the world's largest Research Consulting Organization (RCO), receives Medidata Accreditation for the RAVE EDC Module, Enhancing Clinical Trial Efficiency and Data Integrity for sponsors RALEIGH, N.C., April 18, 2024 /PRNewswire/ -- ProPharma https://www.propharmagroup.com, the... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 18, 2024 Category: Pharmaceuticals Source Type: news
Strategies for Biomarker-Driven Sub-population Optimization in Clinical Trials, Upcoming Webinar Hosted by Xtalks
In this free webinar, review and understand the transformative impact of a biomarker-driven approach to identify sub-populations in clinical trials. Attendees will discover how artificial intelligence (AI) can expedite the analysis of clinical data sets and identify promising patient... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 18, 2024 Category: Pharmaceuticals Tags: FVT TRI Source Type: news
Cancer Stage vs Mortality Endpoints in Screening Trials? Cancer Stage vs Mortality Endpoints in Screening Trials?
In clinical trials of cancer screening, the incidence of late-stage cancer works as well as cancer-specific mortality as an endpoint for some cancers but not others.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Pisano speaks with AuntMinnie.com on new ARPA-H leadership role
Etta Pisano, MD, has been involved in leading many clinical trials, but a new initiative she was tapped to lead may help reach underserved areas faster. Pisano is chief research officer for the American College of Radiology (ACR) and study chair of the Tomosynthesis Mammographic Imaging Screening Trial (TMIST). She is now also leading the Advancing Clinical Trials Readiness initiative, part of the Advanced Research Projects Agency for Health (ARPA-H). “[The initiative] is focused on improving clinical trials, making them faster, better, cheaper, and more equitable to Americans,” she told AuntMinnie.com. ARPA-H is a ...
Source: AuntMinnie.com Headlines - April 18, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Imaging Leaders Source Type: news
Eli Lilly's weight loss drug reduces sleep apnea, study shows
Eli Lilly's weight loss-related drug Zepbound could potentially be used to reduce the severity of sleep apnea in adults with obesity, according to a recent study. Results of a phase three clinical trial, published Wednesday, showed that injections of the drug, either 10 mg or 15 mg, "significantly…#elililly #specificallylilly #zepbound #lilly #jeffemmick #wegovy #fda #novonordisk (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2024 Category: Consumer Health News Source Type: news
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports
The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk ’s Wegovy. (Source: NYT Health)
Source: NYT Health - April 17, 2024 Category: Consumer Health News Authors: Gina Kolata Tags: Tirzepatide Apnea (Sleep Disorder) Drugs (Pharmaceuticals) Obesity Weight Clinical Trials Eli Lilly and Company Source Type: news
Sage Therapeutics ’ stock plunges as Parkinson’s drug trial disappoints
Sage Therapeutics shares dropped early Wednesday after the company said its experimental treatment for mild cognitive impairment in patients with Parkinson’s disease fell flat in a clinical trial. (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2024 Category: Consumer Health News Source Type: news
Longevity startup Loyal is working on a drug to extend the lifespan of dogs
From Bay Area Inno.
When Loyal CEO Celine Halioua received a letter from the FDA offering approval of the effectiveness of its drug, it felt like the best day of her life. The company, which is developing therapies to extend the lifespan of dogs, is the first of a handful of similar startups that has made it to the next stage of development: clinical trials. Last November, the FDA approved the Reasonable Expectation of Effectiveness section in Loyal’s application for conditional approval of… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 17, 2024 Category: Pharmaceuticals Authors: Elizabeth Moss Source Type: news
Electronic Health Records to Electronic Data Capture: Enhancing the Data Journey in Oncology Clinical Trials, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn what electronic health record (EHR) to electronic data capture (EDC) is and the benefits of EHR to EDC connectivity for both the site and sponsor (time, cost and data quality). The featured speakers will share perspectives from both the contract research... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 17, 2024 Category: Pharmaceuticals Tags: FVT TRI Source Type: news
